What to say when you haven’t said anything for a long time? Some say it’s best to pretend nothing happened and carry on, others say you can give an explanation. Well, I don’t have a great explanation, but here it goes: I tried to maintain the blog while also keeping...
Newsletter Articles
Category
Featured
Articles
November highlights from the Biopharma Newsletter
Some of you might have noticed that I stopped publishing my regular newsletter on the blog—some of you might be here for the first time and don’t even know I have a newsletter. 😊 I stopped publishing here every week because I felt it was a bit of a repetition, and it...
This week, less is more
First, we go local, with two announcements from the European Medicines Agency (EMA). Then, an article about the micro level checks on which existing molecules can be repurposed to treat SARS-CoV-2. Lastly, a Science article reveals that excipients (drug...
How AI and gaming can improve pharma and medtech
This week we have another COVID-19-free edition, because I’m somewhat tired of the coronavirus merry-go-round of information. Also, at the time of writing this, it’s 34ºC outside, which I deem too hot to further exert my brain by trying to decide if the study that I...
Biopharma this week—(nearly) COVID-free edition
Hey, Microsoft! Read my notes Software giant Microsoft announced the release of an Azure update that will enable users to extract insights from medical data. The Text Analytics for health is available now as a preview and uses Natural Language Processing (NPL) to find...
COVID-19 long haulers, smell tests, and other updates
This week's highlights go to a relatively unknown face of COVID-19, the role of smell tests in case detection, plus new developments in the vaccines & treatments race. Enjoy the focused bits of knowledge! Another face of COVID-19: long haulers There’s a trend I’ve...
What do toilet paper and dexamethasone have in common?
This week’s roundup features dexamethasone (again), IT collaboration, telemedicine issues, and vaccine manufacturing. Enjoy! What do toilet paper and dexamethasone have in common? In addition to their (mainly) white appearance, toilet paper and dexamethasone have the...
RECOVERY trial, antibodies, and other news
Hi there, This week I bring you some of the weeks’ news that caught my attention. The first one will only be news for you if you’ve been hiding under a rock or swamped with work—in any case, I have your back 😊 Then, we revisit the antibody (or lack of) subject, try to...
We have remdesivir…while we wait for something better
Hi there, Another week, another roundup of the new developments in drugs for COVID-19, the many things that happened on the 10th of June, and other things that caught my eye. Enjoy! REMDESIVIR AROUND THE WORLD Gilead’s remdesivir is being granted conditional...
The mysterious case of the retracted studies
Hi there! This week I have a roundup of the new(ish) things in COVIDland, including a flashback to the eighties and how collaboration can take a project to the next level. Enjoy 😊 PAC-MAN AGAINST COVID-19 Has the yellow video game character retuned from the eighties?...
How do we stop the discrimination virus?
This week, I want to explore how belonging to a community is essential to us, in our personal and work lives. And unfortunately, how some communities are failing us. The idea for this post came from a feeling of gratitude for being a part of some local and virtual...
All Categories
Drug development & clinical trials
Biomedical communications
Writing skills
SEO & medical copywriting
Medical devices
Newsletter
Join
Join my newsletter
Discover trends, gather insights and collect resources that help you thrive in your career. Every Tuesday, straight to your inbox.